Psycho-Oncological Intervention Through Counseling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine (COUNTHY, NCT05054634): A Non-randomized Controlled Study

Nuria Javaloyes; Aurora Crespo; M Carmen Redal; Antonio Brugarolas; Lara Botella; Vanesa Escudero-Ortiz; Manuel Sureda

doi:10.3389/fpsyg.2022.767093

Psycho-Oncological Intervention Through Counseling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine (COUNTHY, NCT05054634): A Non-randomized Controlled Study

Front Psychol. 2022 Feb 25:13:767093. doi: 10.3389/fpsyg.2022.767093. eCollection 2022.

Authors

Nuria Javaloyes¹, Aurora Crespo², M Carmen Redal³, Antonio Brugarolas¹, Lara Botella¹, Vanesa Escudero-Ortiz⁴, Manuel Sureda¹

Affiliations

¹ Plataforma de Oncología, Hospital Quirónsalud Torrevieja, Torrevieja, Spain.
² Servicio de Medicina Nuclear, Hospital Universitari Sant Joan, Alicante, Spain.
³ Servicio de Medicina Nuclear, Hospital Clínico Universitario de Valencia, Valencia, Spain.
⁴ Facultad de Ciencias de la Salud, Grupo de Investigación en Farmacia y Nutrición Clínica, Universidad CEU Cardenal, Elche, Spain.

Abstract

Background: Diagnosis and treatment of differentiated thyroid carcinomas (DTC) cause anxiety and depression. Additionally, these patients suffer hormonal alterations that are associated with psychological symptoms (e.g., changes in mood, emotional instability, and memory loss). This study aims to evaluate the effectiveness of a psycho-oncological intervention based on counseling to reduce anxiety and depression related to the treatment in patients with DTC.

Methods: A non-randomized controlled study, with two groups [experimental group (EG), n = 37, and control group (CG), n = 38] and baseline and posttreatment measures, was designed. Patients in the EG received a psycho-oncological intervention based on counseling in addition to the standard treatment. The independent variable was the assigned group and the dependent one was the evolution of anxiety and depression, which were analyzed separately, and both were evaluated using the Hospital Anxiety and Depression Scale. Other relevant covariables related to the quality of life (QoL) were also analyzed using Short Form-36 Health Survey and Psychological General Wellbeing Index scales.

Results: The difference of the posttreatment-baseline variation showed a statistically significant reduction in anxiety and depression in the EG in relation to the CG (p < 0.001). The mean of the Psychological General Wellbeing Index scales score increased significantly in the EG (p < 0.001) and decreased significantly in the CG (p < 0.001). All the baseline and the posttreatment scores of the variables evaluated showed a statistically significant improvement in the EG vs. the CG.

Conclusion: This study demonstrates significant benefits of psycho-oncological intervention based on counseling in anxiety, depression, QoL, and wellbeing of the patient with differentiated thyroid carcinomas.

Keywords: cancer; oncology; psycho-oncology; psychotherapy; quality of life; radioisotope therapy; thyroid cancer.